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A chromosomally encoded class D -lactamase, OXA-114, was characterized from Achromobacter xylosoxi-
dans strain CIP69598. -Lactamase OXA-114 shared 56% amino acid identity with the naturally occurring
class D -lactamase of Burkholderia cenocepacia and 42% identity with the acquired oxacillinases OXA-9 and
OXA-18. OXA-114 has a narrow-spectrum hydrolysis profile, although it includes imipenem, at a very low level.
PCR and sequencing revealed that blaOXA-114-like genes were identified in all A. xylosoxidans strains tested
(n  5), indicating that this -lactamase is naturally occurring in that species. Induction experiments with
imipenem and cefoxitin did not show inducibility of blaOXA-114 expression.
Achromobacter xylosoxidans (previously Alcaligenes xylosoxi-
dans) is a non-glucose-fermenting gram-negative species that is
increasingly recognized as a clinically significant nosocomial
pathogen. With its tendency to contaminate fluid, many out-
breaks have been reported, mostly in immunocompromised
hosts, causing serious infections, including bacteremia (4, 9).
The organism has variable susceptibility to -lactams (8). It is
mostly resistant to narrow-spectrum penicillins and to several
cephalosporins, including cefotaxime, whereas susceptibility to
ureidopenicillins and carbapenems varies (8). However, acqui-
sition of metallo--lactamases, such as IMP-1, VIM-1, or
VIM-2, has been reported for A. xylosoxidans, therefore lead-
ing to high-level resistance to carbapenems (12, 17–20).
The intrinsic -lactamases produced by A. xylosoxidans have
been characterized only biochemically. Le´vesque et al. re-
ported three types of cephalosporinases, with isoelectric points
(pIs) of 7.4, 9.3, and 8.1 and molecular masses of 32.3 kDa,
22.800 kDa, and 36.200 kDa, respectively (13). Fujii et al.
characterized a penicillinase with an unusually high pI of 9.8
and a molecular mass of 18 kDa (5). Philippon et al. reported
a penicillinase with a pI of 5.7 and an oxacillinase with a pI of
7.7 (3, 15). None of the -lactamase genes have been identified
so far. The present study was designed to identify and to
characterize, at the genetic and biochemical levels, the natu-
rally occurring -lactamase(s) of A. xylosoxidans.
MATERIALS AND METHODS
Bacterial strains and plasmids. A. xylosoxidans reference strain CIP69598
(Pasteur Institute strain collection) and four clinical isolates recovered at the
Biceˆtre hospital (MER, TB1, LOL, and DUC) were included in the study.
Identification was performed with the API 32-GN system (bioMerieux, Marcy
l’Etoile, France). Escherichia coli TOP10 (Invitrogen, Cergy Pontoise, France)
was used as the host for cloning experiments. Kanamycin-resistant pBK-CMV
plasmid (Stratagene, Amsterdam, The Netherlands) was used as the cloning
vector. Bacterial cultures were routinely grown in Trypticase soy (TS) broth at
37°C.
Antimicrobial agents and susceptibility testing. MICs of various -lactams
were determined by an agar dilution technique, as previously described (16).
Results of susceptibility testing were interpreted according to the guidelines of
the Clinical and Laboratory Standards Institute (CLSI) (1).
Cloning experiments and analysis of recombinant plasmids. Genomic DNA
from A. xylosoxidans CIP69598 was extracted and digested partially with restric-
tion enzyme Sau3AI (New England Biolabs, Ipswich, MA). The resultant DNA
fragments were ligated with BamHI-digested pBK-CMV as described previously
(16). E. coli strain TOP10 was transformed with these recombinant plasmids by
electroporation (Gene Pulser II; Bio-Rad Laboratories, Ivry-sur-Seine, France).
Transformants were selected on TS agar containing ticarcillin (50 mg/liter) and
kanamycin (30 mg/liter). The recombinant plasmid was purified with a Qiagen
plasmid mini kit (Qiagen, Courtaboeuf, France) and sequenced on both strands
by use of an ABI 3100 sequencer (Applied Biosystems, Foster City, CA). The
nucleotide and deduced protein sequences were analyzed with software available
over the Internet (www.ncbi.nlm.nih.gov).
Genotyping comparison of the five A. xylosoxidans isolates was performed
using the random amplified polymorphic DNA detection technique as described
previously (21).
PCR experiments and genotyping. The blaOXA genes of the studied strains
were amplified by use of external primers OXA-114A (5-ACGCCTGAACCC
TTTTATCC-3) and OXA-114B (5-ATCGACAGGCCGCGCAGT-3) to pro-
duce a 1,025-bp fragment. Both strands of the PCR products were then se-
quenced.
IEF analysis and hydrolytic and induction studies. Isoelectric focusing (IEF)
analysis was performed with a pH 3.5 to 9.5 Ampholine polyacrylamide gel (GE
Healthcare), using crude extracts of the A. xylosoxidans isolates and of E. coli
TOP10 harboring p6S3 (16). The inducibility of -lactamase production in A.
xylosoxidans isolates CIP69598 and LOL was tested in TS broth at 37°C, using
imipenem (1 g/ml) and cefoxitin (50 g/ml) as inducers, as described previously
(11), and hydrolysis was measured with 100 M of benzylpenicillin or imipenem
as the substrate. The -lactamase activity was defined as follows: 1 unit of
enzyme was the amount that hydrolyzed 1 mol of substrate per min. The total
protein content was measured with bovine albumin as the standard (DC protein
assay kit; Bio-Rad).
-Lactamase purification. The -lactamase was purified as previously de-
scribed, with some modifications (11). E. coli TOP10(p6S3) was cultured over-
night in 4 liters of TS broth containing 30 g/ml of kanamycin and 50 g/ml of
ampicillin. After centrifugation, the bacterial pellet was resuspended in 30 ml of
100 mM phosphate buffer (pH 7.0). Crude protein extracts were then obtained
by sonication followed by centrifugation. After spermine treatment for precipi-
tation of DNA, the supernatant was subjected to several purification steps,
including ion-exchange chromatography with a Q-Sepharose column, first with
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20 mM Tris-HCl buffer (pH 8.8), followed by chromatography on an S-Sepharose
column equilibrated with 20 mM bis-Tris buffer (pH 6.5). Elution of the -lac-
tamase was performed with a linear K2SO4 gradient (0 to 500 mM). Peaks of
-lactamase activity were pooled and dialyzed against 50 mM phosphate buffer
(pH 7.0). The protein content was measured by the Bio-Rad DC protein assay,
and the specific activities of the crude extract and the purified -lactamase from
E. coli TOP10(p6S3) were compared. The protein purification rate and the
relative molecular mass of -lactamase OXA-114a were estimated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis.
Kinetic studies. Purified -lactamase was used for determination of kinetic
parameters (kcat and Km) at 30°C in a reaction buffer made of 100 mM Tris-
H2SO4–300 mM K2SO4 (pH 7.0), in which NaHCO3 was added to a final
concentration of 10 mM in order to avoid biphasic kinetics (14). The initial rates
of hydrolysis of -lactams were determined with a UV spectrophotometer as
previously described (10). Due to a too-low Km value for piperacillin, a Ki value
was obtained by competition, using benzylpenicillin as a reporter substrate. The
50% inhibitory concentration was determined as the clavulanate, tazobactam, or
sulbactam concentration that reduced the hydrolysis rate of 100 M of cephalo-
FIG. 1. Dendrogram obtained for representative class D -lactamases by neighbor-joining analysis. The alignment used for tree calculation was
performed with ClustalX. Branch lengths are drawn to scale and are proportional to the number of amino acid changes. The distance along the
vertical axis has no significance. The amino acid identity of each -lactamase compared to OXA-114a is indicated in parentheses. Acquired
-lactamases in gram-negative organisms are OXA-1, OXA-9, OXA-18, OXA-20, OXA-2, OXA-58, OXA-40, OXA-23, OXA-10, and OXA-48,
whereas the others are naturally occurring ones.
TABLE 1. MICs of -lactams for A. xylosoxidans strain CIP69598, E. coli TOP10 harboring recombinant plasmid p6S3, expressing the
-lactamase OXA-114a, and E. coli TOP10 (reference strain)
-Lactam(s)a
MIC (g/ml) for organism
A. xylosoxidans
CIP69598
A. xylosoxidans
MER
A. xylosoxidans
LOL
A. xylosoxidans
DUC
A. xylosoxidans
TB1
E. coli
TOP10(p6S3)
E. coli
TOP10
Amoxicillin 16 2 64 1 8 16 2
Amoxicillin plus CLA 4 1 8 1 8 16 2
Ticarcillin 4 1 64 1 1 4 2
Ticarcillin plus CLA 4 1 64 1 1 4 2
Piperacillin 1 1 4 1 2 4 1
Piperacillin plus TZB 0.5 0.5 4 0.5 1 4 1
Cephalothin 64 32 64 32 32 8 2
Cefuroxime 64 64 64 64 64 4 2
Ceftazidime 4 16 4 8 4 0.06 0.06
Cefotaxime 64 64 64 64 64 0.25 0.12
Cefepime 64 64 64 64 64 0.12 0.06
Cefoxitin 64 64 64 64 64 4 4
Moxalactam 2 2 1 2 2 1 1
Aztreonam 64 64 64 64 64 0.12 0.12
Imipenem 4 1 4 1 1 0.06 0.06
a CLA, clavulanic acid at a fixed concentration of 4 g/ml; TZB, tazobactam at a fixed concentration of 4 g/ml.
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thin by 50% under conditions in which the enzyme was preincubated with various
concentrations of inhibitor for 3 min at 30°C before addition of the substrate.
Nucleotide sequence accession number. The nucleotide sequences for OXA-
114a reported in this paper have been submitted to the EMBL/GenBank nucle-
otide sequence database under accession number EU188842.
RESULTS AND DISCUSSION
-Lactam resistance phenotypes of study strains. The five
studied A. xylosoxidans strains were resistant to cefotaxime,
cefoxitin, cefepime, and aztreonam, as usually observed in that
species. They were susceptible to piperacillin, moxalactam, and
imipenem according to the CLSI criteria (Table 1). Suscepti-
bility to ticarcillin and ceftazidime was variable, with resistance
to those -lactam molecules being observed only for strains
LOL and MER. Although all isolates were susceptible to imi-
penem, various MICs were obtained (Table 1). Since such a
phenomenon might have resulted from variable expression of
a carbapenemase, imipenem hydrolysis was measured and
showed weak interstrain variability, with 3, 5, and 12 mU per
mg of protein for isolates CIP, MER, and LOL, respectively,
without a correlation with the MICs of imipenem (Table 1).
IEF analysis revealed an identical pI value of 8.6 obtained with
cultures of each isolate. Two other bands were also detected
for those isolates, with pI values of approximately 5.5 and 9.5.
Cloning and sequencing of the -lactamase gene. Repeated
cloning experiments yielded only a single E. coli clone after
selection on ticarcillin- and kanamycin-containing plates. Re-
combinant strain E. coli TOP10(p6S3) possessed a 1,176-bp
plasmid insert and was resistant to amoxicillin and piperacillin,
a resistance pattern which was not inhibited by clavulanic acid
and tazobactam, respectively (Table 1). Sequencing of plasmid
p6S3 revealed an open reading frame consisting of 828 bp,
corresponding to a 275-amino-acid protein. Sequence analysis
indicated that this open reading frame corresponded to a novel
class D -lactamase. The closest identity was observed with
putative naturally occurring -lactamases of Burkholderia
cenocepacia and Delftia acidovorans, with up to 50% amino
acid sequence identity (GenBank accession no. ABK10118.1
and EAV77675.1, respectively) and 37% identity with the ac-
quired oxacillinases OXA-9 and OXA-18 (Fig. 1) (16, 22). This
novel -lactamase from A. xylosoxidans was designated OXA-
114a (since other variants were subsequently identified) (see
below). OXA-114a possessed the conserved motifs of serine
-lactamases, such as S-T-F-K at positions 70 to 73 and the
K-T-G motif at positions 216 to 218, according to the class D
-lactamase numbering scheme (2). The Y-G-N and Q-X-X-
X-L motifs, characteristic of an oxacillinase, were identified at
positions 144 to 146 and 176 to 180, respectively. The pI value
of the mature OXA-114a protein was 8.6, and its molecular
mass was ca. 27 kDa.
Detection of OXA-114-like -lactamase genes in A. xylosoxi-
dans isolates. Four additional A. xylosoxidans isolates were
screened for the presence of blaOXA-114a. Preliminary random
amplified polymorphic DNA genotyping showed that the five
strains were not clonally related (data not shown). PCR am-
plification performed with primers specific for blaOXA-114a
yielded amplicons from all the studied strains. Sequencing
identified four other OXA-114-like sequences (OXA-114b to
OXA-114e) sharing high amino acid identity, with a maximum
FIG. 2. Amino acid sequence comparison of OXA-114-like determinants. OXA-114a is from A. xylosoxidans isolate CIP69598, OXA-114b is
from isolate MER, OXA-114c is from isolate TB1, OXA-114d is from isolate LOL, and OXA-114e is from isolate DUC. Dashes show identical
amino acid residues, and the critical motifs for class D -lactamases are shaded in gray. Numbering is done according to class D nomenclature (2).
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four-amino-acid difference between each other. None of the
variable residues were located in conserved sequences typical
of oxacillinases (Fig. 2).
Kinetic parameters of OXA-114a. After purification, the pu-
rity of the OXA-114a extract was estimated to be 90% by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis,
with a yield of 250 g per liter of culture. The purification
coefficient was estimated to be 35-fold. Kinetic measurements
of purified OXA-114a indicated an overall weak catalytic effi-
ciency toward -lactams. However, efficient hydrolysis of pip-
eracillin and, to a lesser extent, ticarcillin was noticed (Table
2). Oxacillin hydrolysis was not detected with OXA-114a, as
previously observed for other oxacillinases, such as the natu-
rally occurring OXA-50 from Pseudomonas aeruginosa (6). No
hydrolysis was detected for expanded-spectrum cephalospo-
rins, such as ceftazidime, cefoxitin, and cefepime. Thus, the
resistance observed for the last two substrates in all the clinical
isolates was likely not related to the -lactamase OXA-114.
Interestingly, a detectable hydrolysis of imipenem was ob-
served. However, kcat values could not be obtained for imi-
penem because of a very high Km value (2,000 M), indicat-
ing a very poor affinity for that substrate. Hydrolysis of
imipenem by OXA-114a was in accordance with the hydrolysis
of that substrate determined with culture extracts obtained
from the clinical isolates. This result suggested that this -lac-
tamase could be expressed in those isolates, even at a low level.
As observed for most oxacillinases, -lactamase OXA-114a
was not inhibited by class A -lactamase inhibitors.
Induction experiments. Using imipenem and cefoxitin as
inducers, no significant increase in hydrolysis was noticed for
both benzylpenicillin and imipenem as substrates, likely indi-
cating that expression of OXA-114 was not inducible. This
result fits with the lack of induction of many naturally occur-
ring oxacillinases, as observed for OXA-50 in P. aeruginosa (6)
or OXA-51/69 in Acinetobacter baumannii (11), whereas induc-
ibility of oxacillinase OXA-60 from another gram-negative aer-
obe, Ralstonia pickettii, was observed (7).
Conclusions. This study contributed to unraveling at least
one of the natural mechanisms of resistance to -lactams in A.
xylosoxidans. This work identified the naturally occurring -lac-
tamase of A. xylosoxidans as being neither a penicillinase nor a
cephalosporinase, as previously suggested (5, 13), but rather a
narrow-spectrum class D -lactamase. It is likely that the con-
tribution of OXA-114-like enzymes to the final -lactam resis-
tance profile of most A. xylosoxidans strains may be secondary,
as previously demonstrated for naturally occurring oxacilli-
nases of other gram-negative aerobic species, such as OXA-
50-like enzymes from P. aeruginosa or OXA-51/69 from A.
baumannii. However, since it is known that expression of that
latter -lactamase gene could be enhanced by the presence of
insertion sequence elements providing promoter sequences
(ISAba1 in A. baumannii), it might be hypothesized that similar
events could also be expected for blaOXA-114-like genes in A.
xylosoxidans, leading to a higher level of OXA-114-mediated
-lactam resistance. The present study strengthens the obser-
vation that numerous gram-negative aerobes harbor naturally
occurring class D -lactamase genes in their chromosomes and
constitute possible sources of resistance genes.
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